| | ||||||||
| "anti diabetes" | ||||||||
| NEWS | ||||||||
Lupin, Boehringer Ingelheim to co-market anti-diabetes drug linagliptin in India Announcing the co-marketing alliance, the two companies said that Lupin's 400-strong diabetes-focussed field force would market the drug under the ...
| ||||||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.